0001231919-25-000557.txt : 20251126 0001231919-25-000557.hdr.sgml : 20251126 20251126155559 ACCESSION NUMBER: 0001231919-25-000557 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251126 DATE AS OF CHANGE: 20251126 EFFECTIVENESS DATE: 20251126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Somite Therapeutics, Inc. CENTRAL INDEX KEY: 0002075078 ORGANIZATION NAME: EIN: 934020401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-565224 FILM NUMBER: 251529878 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET STREET 2: FOURTH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 512-270-9113 MAIL ADDRESS: STREET 1: 40 GUEST STREET STREET 2: FOURTH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 D 1 primary_doc.xml X0708 D LIVE 0002075078 Somite Therapeutics, Inc. 40 GUEST STREET FOURTH FLOOR BOSTON MA MASSACHUSETTS 02135 512-270-9113 DELAWARE None None Corporation true 2023 Micah Breakstone 40 GUEST STREET FOURTH FLOOR BOSTON MA MASSACHUSETTS 02135 Executive Officer Director Promoter Chad Cowan 40 GUEST STREET FOURTH FLOOR BOSTON MA MASSACHUSETTS 02135 Director Steven Holtzman 40 GUEST STREET FOURTH FLOOR BOSTON MA MASSACHUSETTS 02135 Director Other Decline to Disclose 06b false 2025-04-11 false true false 0 47499943 47499943 0 false 30 0 0 0 false Somite Therapeutics, Inc. /s/ Micah Breakstone Micah Breakstone Chief Executive Officer 2025-11-26